School of Pharmacy, Nanjing University of Chinese Medicine, 210046 Nanjing, China.
School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, 210046 Nanjing, China.
Oxid Med Cell Longev. 2022 Feb 7;2022:6934812. doi: 10.1155/2022/6934812. eCollection 2022.
Xijiao Dihuang Tang (XDT), a classic TCM prescription, has been used to clinically treat blood-heat and blood-stasis syndrome- (BHSS-) related diseases, including hemorrhagic stroke and sepsis. However, the active constituents and mechanism of XDT in the treatment of BHSS-related diseases have not been elucidated due to the lack of appropriate methodologies. In this study, serum pharmacochemistry and network pharmacology were used to explore the active constituents and the mechanism of XDT in the treatment of BHSS-related diseases. The effects of XDT were evaluated using dry yeast-induced rats as rat models with BHSS, which demonstrated the antipyretic and anticoagulant properties of XDT. The HPLC-QTOF/MS/MS assay was used to identify 60 serum constituents of XDT (SCXDT). Then, 338 targets of 60 SCXDT were predicted by integrating multiple databases and the MACCS fingerprint similarity prediction method. The degree of topological properties with targets of 19 key active constituents in SCXDT was identified and evaluated in glutamate-induced PC12 cells. Subsequently, 338 targets of 60 SCXDT were mainly involved in biological processes such as inflammation, coagulation, cell proliferation, and apoptosis, as well as oxidative contingencies via compound-target-disease network analysis. The core targets including IL-1, IL-6, TNF, NOS3, and MAPK1 were identified using protein-protein interaction network analysis, whereas dozens of signaling pathways such as the p38MAPK signaling pathway were identified using functional pathway enrichment analysis. The results indicated that XDT has broad therapeutic and neuroprotective effects on inflammation, coagulation, oxidative stress, cell proliferation, and apoptosis in dry yeast-induced rats with BHSS and glutamate-induced PC12 cells by regulating the p38MAPK signaling pathway. This study not only discovered the active constituents of XDT but also elaborated its mechanisms in the treatment of BHSS-related diseases by intervening in a series of targets, signaling pathways, and biological processes such as inflammation, coagulation, oxidative stress, neuroprotection. The findings in this study provide a novel strategy for exploring the therapeutic efficacy of TCM prescriptions.
血府逐瘀汤(XDT)是一种经典的中药方剂,已临床用于治疗血热血瘀证(BHSS)相关疾病,包括出血性中风和脓毒症。然而,由于缺乏适当的方法,XDT 治疗 BHSS 相关疾病的活性成分和机制仍未阐明。在这项研究中,采用血清药物化学和网络药理学方法探讨 XDT 治疗 BHSS 相关疾病的活性成分和机制。使用干酵母诱导的具有 BHSS 的大鼠作为大鼠模型来评估 XDT 的作用,该模型证明了 XDT 的解热和抗凝作用。采用高效液相色谱-四极杆飞行时间质谱联用(HPLC-QTOF/MS/MS)法鉴定 XDT 的 60 种血清成分(SCXDT)。然后,通过整合多个数据库和 MACCS 指纹相似性预测方法,预测 60 种 SCXDT 的 338 个靶标。通过鉴定和评估 19 种关键活性成分的 338 个靶标在谷氨酸诱导的 PC12 细胞中的拓扑性质,确定了它们的程度。随后,通过化合物-靶标-疾病网络分析,对 60 种 SCXDT 的 338 个靶标主要涉及炎症、凝血、细胞增殖和凋亡以及氧化应激等生物学过程进行了分析。通过蛋白质-蛋白质相互作用网络分析,确定了核心靶标包括 IL-1、IL-6、TNF、NOS3 和 MAPK1,而通过功能途径富集分析,确定了数十个信号通路,如 p38MAPK 信号通路。结果表明,XDT 对干酵母诱导的具有 BHSS 的大鼠和谷氨酸诱导的 PC12 细胞具有广泛的治疗和神经保护作用,可通过调节 p38MAPK 信号通路,调节炎症、凝血、氧化应激、细胞增殖和凋亡等一系列靶标、信号通路和生物学过程。该研究不仅发现了 XDT 的活性成分,还通过干预一系列靶标、信号通路和生物学过程,如炎症、凝血、氧化应激、神经保护,阐述了其治疗 BHSS 相关疾病的机制。该研究为探索中药方剂的治疗效果提供了一种新策略。